Cancer Family
Neoplasm
CI-CAN-00000001Explore in graph →
Non-malignant22,971 active trials259 approved drugs4,031 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000001Explore in graph →
Clinical trials
105,884 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05942456 | Soluble B7-H3 as a Biomarker for Osteosarcoma | unknown | — | 200 | Peking University People's HospitalOTHER | 1 | May 14, 2024 | clinicaltrials |
| NCT05957822 | Goal-directed vs Preemptive Tranexamic Acid Administration in Non-cardiac Surgery | unknown | Phase 4 | 148 | Konkuk University Medical CenterOTHER | 1 | May 14, 2024 | clinicaltrials |
| NCT06173999 | A Study of SHR2554 With Chemotherapy in Treatment-naïve Patients With Peripheral T-cell Lymphoma | unknown | Phase 1 / Phase 2 | 100 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | May 14, 2024 | clinicaltrials |
| NCT06412068 | A Prospective Study: Sintilimab and R-CHOP in PMBCL Treatment | unknown | Phase 2 | 32 | Sun Yat-sen UniversityOTHER | 0 | May 14, 2024 | clinicaltrials |
| NCT06412133 | Conversations in Light and Shadow: Assessing Phototherapy's Impact on Breast Cancer Patients | unknown | N/A | 57 | Yun-Chen ChangOTHER | 1 | May 14, 2024 | clinicaltrials |
| NCT06412211 | A Clinical Feasibility Study of a Photoacoustic Finder | unknown | — | 129 | Seoul St. Mary's HospitalOTHER | 1 | May 14, 2024 | clinicaltrials |
| NCT06412419 | Multimodal Endoscopic Image Fusion for Assessing Infiltration in Superficial Esophageal Squamous Cell Carcinoma | unknown | — | 450 | Changhai HospitalOTHER | 1 | May 14, 2024 | clinicaltrials |
| NCT06412458 | IM83 Clinical Study of CAR-T Cell Therapy in Patients With Relapsed or Refractory Osteosarcoma | unknown | Phase 1 | 9 | Beijing Immunochina Medical Science & Technology Co., Ltd.INDUSTRY | 1 | May 14, 2024 | clinicaltrials |
| NCT06412692 | Motivational Interviewing in Adolescents With Epilepsy | unknown | N/A | 72 | Izmir Katip Celebi UniversityOTHER | 1 | May 14, 2024 | clinicaltrials |
| NCT06412952 | 68Ga-NOTA-RM26 PET/CT in Glioma Patients | unknown | Early Phase 1 | 30 | Peking Union Medical College HospitalOTHER | 1 | May 14, 2024 | clinicaltrials |
| NCT02661503 | HD21 for Advanced Stages | unknown | Phase 3 | 1,500 | University of CologneOTHER | 1 | May 13, 2024 | clinicaltrials |
| NCT05811195 | Comparison of Prophylactic Photobiomodulation Protocols in Chemoinduced Oral Mucositis in Oncology Patients | unknown | N/A | 34 | Federal University of Rio Grande do SulOTHER | 1 | May 13, 2024 | clinicaltrials |
| NCT06148402 | Fruquintinib Plus Camrelizumab and Capecitabine as Salvage Therapy After Progression on FOLFOXIRI-based First-line Treatment in Patients With Unresectable/Metastatic Colorectal Cancer | unknown | Phase 2 | 30 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | May 13, 2024 | clinicaltrials |
| NCT06410677 | Changhai Multimodal Esophageal Cancer Cohort(CMECC) | unknown | — | 110 | WangluoweiOTHER | 1 | May 13, 2024 | clinicaltrials |
| NCT06411470 | Gastrointestinal Microflora and Serum Metabolomics in Patients With Pancreatic Cancer and Chronic Pancreatitis | unknown | — | 600 | Changhai HospitalOTHER | 1 | May 13, 2024 | clinicaltrials |
| NCT01516710 | Oslo Randomized Laparoscopic Versus Open Liver Resection for Colorectal Metastases Study(Oslo-CoMet) | unknown | N/A | 280 | Oslo University HospitalOTHER | 1 | May 10, 2024 | clinicaltrials |
| NCT03004755 | The PEACE (Posthumous Evaluation of Advanced Cancer Environment) Study(PEACE) | unknown | — | 500 | University College, LondonOTHER | 1 | May 10, 2024 | clinicaltrials |
| NCT03337919 | ANIMATE: Phase II Study of Nivolumab Monotherapy for Relapsed/Refractory Hodgkin Lymphoma(ANIMATE) | unknown | Phase 2 | 78 | University College, LondonOTHER | 1 | May 10, 2024 | clinicaltrials |
| NCT04655118 | Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis | unknown | Phase 2 | 121 | Telios Pharma, Inc.INDUSTRY | 13 | May 10, 2024 | clinicaltrials |
| NCT05558436 | Comparison of Diagnostic Sensitivity Between ctDNA Methylation and CEA in Colorectal Cancer | unknown | — | 662 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | May 10, 2024 | clinicaltrials |
| NCT05832320 | Optimum Induction Therapy of Low-risk APL | unknown | N/A | 74 | Peking University People's HospitalOTHER | 1 | May 10, 2024 | clinicaltrials |
| NCT06341283 | A Retrospective Real-world Study of Abemaciclib in HR+ Breast Cancer | unknown | — | 200 | The Affiliated Hospital of Qingdao UniversityOTHER | 1 | May 10, 2024 | clinicaltrials |
| NCT06402552 | Comparing Bp-MRI and Mp-MRI for Prostate Cancer Screening Accuracy | unknown | N/A | 370 | Chang Gung Memorial HospitalOTHER | 1 | May 10, 2024 | clinicaltrials |
| NCT06408623 | Chidamide Combined With Sintilimab and Bevacizumab for the First-line Treatment of Advanced Liver Cancer | unknown | Phase 2 | 48 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 0 | May 10, 2024 | clinicaltrials |
| NCT06409039 | POLE-END REAL LIFE: Endometrial Cancer Early Stages I-II and Advanced Stages III and IV Evaluation of POLE as a Prognostic Factor. Participants Are Women >= 18 Years Old, With the Pole Mutation(POLE-END) | unknown | — | 80 | Azienda Ulss 2 Marca TrevigianaOTHER | 1 | May 10, 2024 | clinicaltrials |
| NCT06409195 | A Trial to Study the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratoses and Non-Melanoma Skin Cancers | unknown | Phase 2 | 50 | DermBiont, Inc.INDUSTRY | 1 | May 10, 2024 | clinicaltrials |
| NCT06409221 | VISION: Triple Negative Breast Cancer Sample and Clinical Data Acquisition Study | unknown | — | 200 | ConcrINDUSTRY | 1 | May 10, 2024 | clinicaltrials |
| NCT06409403 | Study on Effect of Robotic Versus Laparoscopic Surgical Technology on Genitourinary Function After Total Mesorectal Excision for Rectal Cancer | unknown | N/A | 164 | general surgery 3OTHER | 1 | May 10, 2024 | clinicaltrials |
| NCT06409481 | Pharmacovigilance Assessment of Reporting of Cardiovascular Adverse Events With Antineoplastic Agents (PARCA)(PARCA) | unknown | — | 800,000 | The First Affiliated Hospital of Xinxiang Medical CollegeOTHER | 0 | May 10, 2024 | clinicaltrials |
| NCT06410040 | A Retrospective Study of the Efficacy and Safety of Lolatinib in ALK+ NSCLC Patients With Brain or Meningeal Metastasis | unknown | — | 28 | Sichuan Cancer Hospital and Research InstituteOTHER | 1 | May 10, 2024 | clinicaltrials |
| NCT01428973 | Minitransplants With HLA-matched Donors : Comparison Between 2 GVHD Prophylaxis Regimens | unknown | Phase 2 | 200 | University of LiegeOTHER | 1 | May 9, 2024 | clinicaltrials |
| NCT02109952 | Biomechanics of Metastatic Defects in Bone | unknown | — | 245 | Beth Israel Deaconess Medical CenterOTHER | 2 | May 9, 2024 | clinicaltrials |
| NCT04159974 | RICE: Radio-Immuno-Chemotherapy of Cancer of the Esophagus(RICE) | unknown | Phase 2 | 56 | University of CologneOTHER | 1 | May 9, 2024 | clinicaltrials |
| NCT04713371 | A Phase 2 Trial for Patients With Metastatic Solid Cancer | unknown | Phase 2 | 32 | Rampart Health, L.L.C.INDUSTRY | 1 | May 9, 2024 | clinicaltrials |
| NCT04755920 | SGM-101 in Colorectal Brain Metastases.(SGM-CBM) | unknown | Phase 2 | 10 | Leiden University Medical CenterOTHER | 1 | May 9, 2024 | clinicaltrials |
| NCT04814953 | HRQoL Keratinocyte Carcinomas | unknown | — | 2,400 | University Hospital, GhentOTHER | 2 | May 9, 2024 | clinicaltrials |
| NCT05385406 | HPV Screening With Triage by HPV Genotyping Versus Visual Inspection With Acetic Acid | unknown | N/A | 5,500 | Prof. Patrick PetignatOTHER | 1 | May 9, 2024 | clinicaltrials |
| NCT05534282 | Music Therapy With Cancer Affected Children and Their Families(INMUT) | unknown | N/A | 52 | University of Witten/HerdeckeOTHER | 1 | May 9, 2024 | clinicaltrials |
| NCT05656716 | Multimodal Project | unknown | N/A | 80 | Universidad de GranadaOTHER | 1 | May 9, 2024 | clinicaltrials |
| NCT05787964 | Immunity to Infection in Healthy Participants and Participants With Cancer(SYS01) | unknown | — | 200 | University Hospital TuebingenOTHER | 1 | May 9, 2024 | clinicaltrials |
| NCT05865756 | Assessment of (Chemo)RT-related Dysphagia in HNC Patients Based on Cough-related Acoustic Features | unknown | N/A | 40 | Jules Bordet InstituteOTHER | 1 | May 9, 2024 | clinicaltrials |
| NCT05878106 | Creatine Supplementation and Resistance Training in Patients With Breast Cancer(CaRTiC) | unknown | N/A | 120 | University of DeustoOTHER | 1 | May 9, 2024 | clinicaltrials |
| NCT05965817 | Fluorescence-guided Resection Of Colorectal Liver Metastases Using SGM-101 and Indocyanine GREEN(FOCUS GREEN) | unknown | Phase 2 | 10 | Leiden University Medical CenterOTHER | 1 | May 9, 2024 | clinicaltrials |
| NCT06251102 | Real-world Ruxolitinib Experience in PV(REVIEW) | unknown | — | 153 | Gruppo Italiano Malattie EMatologiche dell'AdultoOTHER | 0 | May 9, 2024 | clinicaltrials |
| NCT06377267 | Status of HRD That Lead to a Benefit From Olaparib in Combination With Bevacizumab (STROBE Trial)(STROBE) | unknown | Phase 2 | 100 | Vall d'Hebron Institute of OncologyOTHER | 1 | May 9, 2024 | clinicaltrials |
| NCT06406127 | Effect of Alpha Lipoic Acid on Chemotherapy Induced Neurological Changes in Breast Cancer Patients | unknown | Phase 4 | 92 | Ain Shams UniversityOTHER | 1 | May 9, 2024 | clinicaltrials |
| NCT06406322 | Pelvic Floor Dysfunction and Aerobic Training in Gynecological Cancer | unknown | N/A | 40 | Atılım UniversityOTHER | 0 | May 9, 2024 | clinicaltrials |
| NCT06406556 | Safety & Efficacy of Peg-ASP-based CCRT in Early Stage ENKTL(ENKTL) | unknown | Phase 2 | 90 | Sun Yat-sen UniversityOTHER | 1 | May 9, 2024 | clinicaltrials |
| NCT06406608 | Patient-derived Organoid Drug Sensitivity Guided Treatment for Drug-resistant Recurrent Non-Small Cell Lung Cancer | unknown | N/A | 20 | Henan Cancer HospitalOTHER_GOV | 1 | May 9, 2024 | clinicaltrials |
| NCT06406660 | Patient-derived Organoid Drug Sensitivity Guided Treatment for Recurrent Small Cell Lung Cancer | unknown | N/A | 20 | Henan Cancer HospitalOTHER_GOV | 1 | May 9, 2024 | clinicaltrials |
Data updated 24 days agoSource updated May 14, 2024source: clinicaltrials